A randomized double-blind placebo-controlled clinical trial of Green Mate Extract EFLA-920 for treatment of overweight and obesity

被引：0
|
作者：
Kang, Jae Heon
Song, Hong Ji
Kim, Hwa Jung
机构：
[1] Inje Univ, Seoul Paik Hosp, Seoul, South Korea
[2] Hallym Univ, Sacred Heart Hosp, Chunchon, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2007年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [41] Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Wathurapatha, Wasundara S.
    Galappatthy, Priyadarshani
    Katulanda, Prasad
    Jayawardena, Ranil
    Constantine, Godwin R.
    JOURNAL OF DIABETES, 2018, 10 (05) : 386 - 397
  • [42] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [43] Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial
    Shuang Liu
    Xiaojing Lin
    Minghao Tao
    Qi Chen
    Hang Sun
    Yali Han
    Shaoling Yang
    Yining Gao
    Shen Qu
    Haibing Chen
    Lipids in Health and Disease, 23
  • [44] Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double-blind, placebo-controlled trial
    Lu, Difei
    Yuan, Zhenfang
    Guo, Xiaohui
    Zhu, Liyong
    Zhang, Fan
    Li, Xuejun
    Wang, Wenbo
    Lin, Huandong
    Luo, Jingnan
    DIABETES OBESITY & METABOLISM, 2024, 26 (04): : 1224 - 1233
  • [45] Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial
    Liu, Shuang
    Lin, Xiaojing
    Tao, Minghao
    Chen, Qi
    Sun, Hang
    Han, Yali
    Yang, Shaoling
    Gao, Yining
    Qu, Shen
    Chen, Haibing
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [46] Pilocarpine spray for the treatment of xerostomia: a randomized, double-blind, placebo-controlled trial
    Fragoso Motta, Ana Carolina
    Marques, Vanessa Tonetto
    Cabral, Fernanda Fortes
    dos Santos Polvora, Tabata Larissa
    de Macedo, Leandro Dorigan
    Alencar Ramos Inocenttini, Lara Maria
    Ferreira Duarte, Maira Peres
    Oliveira, Fabiola Reis
    Rocha, Eduardo Melani
    de Freitas, Osvaldo
    Tirapelli, Camila
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S319 - S319
  • [47] A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
    Miller, I.
    Lynggaard, C. D.
    Lophaven, S.
    Zachariae, C.
    Dufour, D. N.
    Jemec, G. B. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 391 - 398
  • [48] Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
    Levin, Frances R.
    Mariani, John J.
    Brooks, Daniel J.
    Pavlicova, Martina
    Cheng, Wendy
    Nunes, Edward V.
    DRUG AND ALCOHOL DEPENDENCE, 2011, 116 (1-3) : 142 - 150
  • [49] Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial
    Keshavarzi, Amir
    Sharifi, Aziz
    Jahangard, Leila
    Soltanian, Alireza
    Bruehl, Annette Beatrix
    Ahmadpanah, Mohammad
    Brand, Serge
    NEUROPSYCHOBIOLOGY, 2022, 81 (03) : 192 - 203
  • [50] Metoclopramide for the treatment of Tourette syndrome: A randomized, double-blind, placebo-controlled trial
    Nicolson, R
    Smith, J
    Castellanos, FX
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S277 - S277
12345